tiprankstipranks
Advertisement
Advertisement
Pharma Mar Details January Transactions in Ongoing Share Buyback Programme
PremiumCompany AnnouncementsPharma Mar Details January Transactions in Ongoing Share Buyback Programme
2M ago
Pharma Mar SA Reports Revenue Growth and Key Approvals
Premium
Company Announcements
Pharma Mar SA Reports Revenue Growth and Key Approvals
5M ago
Pharma Mar SA Reports Strong H1 2025 Performance
Premium
Company Announcements
Pharma Mar SA Reports Strong H1 2025 Performance
8M ago
Pharma Mar’s Zepzelca® Shows Promising Results in Lung Cancer Treatment
PremiumCompany AnnouncementsPharma Mar’s Zepzelca® Shows Promising Results in Lung Cancer Treatment
10M ago
Pharma Mar SA Reports on Recent Share Buy-Back Activities
Premium
Company Announcements
Pharma Mar SA Reports on Recent Share Buy-Back Activities
10M ago
PharmaMar Seeks EMA Approval for New Lung Cancer Treatment
Premium
Company Announcements
PharmaMar Seeks EMA Approval for New Lung Cancer Treatment
10M ago
Pharma Mar SA Reports Strong Q1 2025 Revenue Growth
PremiumCompany AnnouncementsPharma Mar SA Reports Strong Q1 2025 Revenue Growth
11M ago
PharmaMar Reports Strong Q1 2025 Financial Growth
Premium
Company Announcements
PharmaMar Reports Strong Q1 2025 Financial Growth
11M ago
Pharma Mar Announces 2025 Shareholders Meeting with Key Governance Proposals
Premium
Company Announcements
Pharma Mar Announces 2025 Shareholders Meeting with Key Governance Proposals
11M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100